ANTI-INFLAMMATORY ACTIVITYOF QUERCETININ ANIMAL MODELS OF CHRONIC INFLAMMATION

Authors

  • Qader G.I. Department of Pharmacology, School of Medicine, Faculty of Medical Sciences, University of Sulaimani, Kurdistan Region, Iraq
  • Ahmed Z.A Department of Pharmacology, School of Medicine, Faculty of Medical Sciences, University of Sulaimani, Kurdistan Region, Iraq
  • Hussain S.A Department of Pharmacology and Toxicology, College of Pharmacy, University of Baghdad, Baghdad, Iraq

Keywords:

quercetin, chronic inflammation, granuloma, rats

Abstract

The side effects of the currently used anti-inflammatory agents are the major problem during their clinical use; therefore, the development of newer, more effective, and safe anti-inflammatory drugs is necessary. The present study evaluates the antiinflammatory activity of quercetin in animal models of chronic and granulomatous inflammation. Forty-eight rats were used
to induce chronic inflammation in the hind paw with formalin and granulomatous inflammation with sterile cotton-wool pellets. The anti-inflammatory activity of quercetin (150 mg/kg, P.O) was evaluated in the two models, and compared with that produced by dexamethasone (1 mg/kg, P.O). Quercetin decreased significantly the formation of exudate and granulation tissue compared with the vehicle, but still significantly lower than that produced by dexamethasone. In conclusion, quercetin inhibits the production of edema and granulation tissue in animal models of chronic and granulomatous inflammation; it could be a potential choice for the treatment of chronic inflammatory disorders.

Downloads

Download data is not yet available.

Published

2014-05-12
Statistics
145 Views | 100 Downloads
Citatons

How to Cite

Qader G.I., Ahmed Z.A, and Hussain S.A. “ANTI-INFLAMMATORY ACTIVITYOF QUERCETININ ANIMAL MODELS OF CHRONIC INFLAMMATION”. International Journal of Pharmaceutics and Drug Analysis, vol. 2, no. 5, May 2014, pp. 454-9, https://ijpda.org/index.php/journal/article/view/75.

Issue

Section

Research Articles
Share |